Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Jaguar Health (JAGX) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to $10.3 million.

  • Jaguar Health's Operating Expenses fell 47.25% to $10.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.6 million, marking a year-over-year increase of 957.24%. This contributed to the annual value of $42.5 million for FY2024, which is 347.77% down from last year.
  • As of Q3 2025, Jaguar Health's Operating Expenses stood at $10.3 million, which was down 47.25% from $11.0 million recorded in Q2 2025.
  • In the past 5 years, Jaguar Health's Operating Expenses registered a high of $14.4 million during Q1 2022, and its lowest value of $9.4 million during Q2 2022.
  • Its 5-year average for Operating Expenses is $11.1 million, with a median of $10.8 million in 2023.
  • Its Operating Expenses has fluctuated over the past 5 years, first skyrocketed by 6662.79% in 2021, then crashed by 2601.15% in 2022.
  • Quarter analysis of 5 years shows Jaguar Health's Operating Expenses stood at $12.9 million in 2021, then decreased by 26.01% to $9.5 million in 2022, then rose by 3.26% to $9.9 million in 2023, then increased by 18.35% to $11.7 million in 2024, then fell by 11.53% to $10.3 million in 2025.
  • Its last three reported values are $10.3 million in Q3 2025, $11.0 million for Q2 2025, and $11.6 million during Q1 2025.